Danielle Brill Score: 45
Analyst at
Truist Financial,
Raymond James
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+25.6%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
74%
23 W / 8 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
86%
18 W / 3 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
14%
3 W / 18 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
5%
1 W / 20 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
81%
17 W / 4 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
73%
22 W / 8 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
100%
1 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| May 27, 2026 |
Apogee Therapeutics Inc.
APGE
|
BUY |
$81.00
Est. +4%
|
$78.07 | $91.90 |
Target Met
|
$88.33
+13.1%
|
| May 27, 2026 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$542.00
Est. +24%
|
$435.93 | $453.68 |
Pending
|
$450.69
+3.4%
|
| Apr 29, 2026 |
BridgeBio Pharma Inc
BBIO
|
BUY |
$102.00
Est. +46%
|
$70.08 | $72.49 |
Pending
|
$68.00
-3.0%
|
| Mar 17, 2026 |
Apogee Therapeutics Inc.
APGE
|
BUY |
$83.00
Est. +19%
|
$69.85 | $95.32 |
Target Met
|
$88.33
+26.5%
|
| Feb 25, 2026 |
BridgeBio Pharma Inc
BBIO
|
BUY |
$95.00
Est. +44%
|
$65.75 | $84.75 |
Pending
|
$68.00
+3.4%
|
| Feb 17, 2026 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$140.00
Est. +9%
|
$128.98 | $169.57 |
Target Met
|
$159.51
+23.7%
|
| Feb 09, 2026 |
Biogen Inc
BIIB
|
SELL |
$193.00
Est. +4%
|
$201.18 | $168.64 (Low) |
Target Met
|
$198.64
+1.3%
|
| Jan 12, 2026 |
Insmed Inc
INSM
|
BUY |
$205.00
Est. +23%
|
$166.26 | $175.12 |
Pending
|
$97.46
-41.4%
|
| Jan 08, 2026 |
Argen X SE - ADR
ARGX
|
BUY |
$1,030.00
Est. +25%
|
$822.94 | $911.88 |
Pending
|
$884.20
+7.4%
|
| Jan 08, 2026 |
Centessa Pharmaceuticals plc - ADR
CNTA
|
BUY |
$33.00
Est. +45%
|
$22.69 | $40.25 |
Target Met
|
$39.76
+75.2%
|
| Jan 08, 2026 |
Tectonic Therapeutic Inc.
TECX
|
BUY |
$60.00
Est. +185%
|
$21.05 | $36.02 |
Pending
|
$30.28
+43.8%
|
| Dec 19, 2025 |
Insmed Inc
INSM
|
BUY |
$202.00
Est. +21%
|
$166.55 | $186.19 |
Pending
|
$97.46
-41.5%
|
| Nov 05, 2025 |
Centessa Pharmaceuticals plc - ADR
CNTA
|
BUY |
$30.00
Est. +57%
|
$19.15 | $40.25 |
Target Met
|
$39.76
+107.6%
|
| Oct 29, 2025 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$172.00
Est. +23%
|
$139.90 | $169.57 |
Precision Hit (±3%)
|
$159.51
+14.0%
|
| Oct 14, 2025 |
Dianthus Therapeutics Inc
DNTH
|
BUY |
$56.00
Est. +63%
|
$34.42 | $96.50 |
Target Met
|
$82.07
+138.4%
|
| Oct 02, 2025 |
Palvella Therapeutics, Inc.
PVLA
|
BUY |
$80.00
Est. +30%
|
$61.69 | $151.18 |
Target Met
|
$108.81
+76.4%
|
| Jul 21, 2025 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$385.00
Est. +19%
|
$324.49 | $495.55 |
Target Met
|
$287.80
-11.3%
|
| Oct 31, 2024 |
Agios Pharmaceuticals Inc
AGIO
|
BUY |
$51.00
Est. +15%
|
$44.43 | $62.58 |
Target Met
|
$31.82
-28.4%
|
| Oct 10, 2024 |
Regenxbio Inc
RGNX
|
BUY |
$18.00
Est. +96%
|
$9.19 | $12.84 |
Miss
|
$7.07
-23.1%
|
| Oct 10, 2024 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$79.00
Est. +14%
|
$69.60 | $73.51 |
Miss
|
$55.65
-20.0%
|
| Oct 10, 2024 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$155.00
Est. +39%
|
$111.62 | $154.61 |
Bullseye Hit (±1%)
|
$159.51
+42.9%
|
| Oct 10, 2024 |
Argen X SE - ADR
ARGX
|
BUY |
$605.00
Est. +16%
|
$520.52 | $808.43 |
Target Met
|
$884.20
+69.9%
|
| Oct 10, 2024 |
Xenon Pharmaceuticals Inc
XENE
|
BUY |
$50.00
Est. +27%
|
$39.42 | $46.00 |
Miss
|
$52.40
+32.9%
|
| Aug 08, 2024 |
Disc Medicine Inc
IRON
|
BUY |
$50.00
Est. +17%
|
$42.85 | $68.73 |
Target Met
|
$67.99
+58.7%
|
| Jun 24, 2024 |
BridgeBio Pharma Inc
BBIO
|
BUY |
$46.00
Est. +103%
|
$22.65 | $44.75 |
Precision Hit (±3%)
|
$68.00
+200.2%
|
| May 10, 2024 |
Disc Medicine Inc
IRON
|
BUY |
$43.00
Est. +44%
|
$29.95 | $68.73 |
Target Met
|
$67.99
+127.0%
|
| Apr 30, 2024 |
Harmony Biosciences Holdings Inc
HRMY
|
BUY |
$37.00
Est. +20%
|
$30.91 | $41.61 |
Target Met
|
$34.18
+10.6%
|
| Apr 01, 2024 |
Disc Medicine Inc
IRON
|
BUY |
$40.00
Est. +36%
|
$29.40 | $68.73 |
Target Met
|
$67.99
+131.3%
|
| Oct 18, 2022 |
Xenon Pharmaceuticals Inc
XENE
|
BUY |
$52.00
Est. +46%
|
$35.52 | - | - |
$52.40
+47.5%
|
| Feb 11, 2022 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$125.00
Est. +46%
|
$85.53 | - | - |
$159.51
+86.5%
|
| Dec 16, 2021 |
uniQure N.V.
QURE
|
BUY |
$58.00
Est. +187%
|
$20.24 | - | - |
$27.87
+37.7%
|
Apogee Therapeutics Inc.
APGE
May 27, 2026
Signal & Target
BUY
$81.00
Start Price
$78.07
Best Price (1Y)
$91.90
Current Price
$88.33
Return
+13.1%
Vertex Pharmaceuticals, Inc.
VRTX
May 27, 2026
Signal & Target
BUY
$542.00
Start Price
$435.93
Best Price (1Y)
$453.68
Current Price
$450.69
Return
+3.4%
BridgeBio Pharma Inc
BBIO
Apr 29, 2026
Signal & Target
BUY
$102.00
Start Price
$70.08
Best Price (1Y)
$72.49
Current Price
$68.00
Return
-3.0%
Apogee Therapeutics Inc.
APGE
Mar 17, 2026
Signal & Target
BUY
$83.00
Start Price
$69.85
Best Price (1Y)
$95.32
Current Price
$88.33
Return
+26.5%
BridgeBio Pharma Inc
BBIO
Feb 25, 2026
Signal & Target
BUY
$95.00
Start Price
$65.75
Best Price (1Y)
$84.75
Current Price
$68.00
Return
+3.4%
Neurocrine Biosciences, Inc.
NBIX
Feb 17, 2026
Signal & Target
BUY
$140.00
Start Price
$128.98
Best Price (1Y)
$169.57
Current Price
$159.51
Return
+23.7%
Biogen Inc
BIIB
Feb 09, 2026
Signal & Target
SELL
$193.00
Start Price
$201.18
Best Price (1Y)
$168.64
Current Price
$198.64
Return
+1.3%
Insmed Inc
INSM
Jan 12, 2026
Signal & Target
BUY
$205.00
Start Price
$166.26
Best Price (1Y)
$175.12
Current Price
$97.46
Return
-41.4%
Argen X SE - ADR
ARGX
Jan 08, 2026
Signal & Target
BUY
$1,030.00
Start Price
$822.94
Best Price (1Y)
$911.88
Current Price
$884.20
Return
+7.4%
Centessa Pharmaceuticals plc - ADR
CNTA
Jan 08, 2026
Signal & Target
BUY
$33.00
Start Price
$22.69
Best Price (1Y)
$40.25
Current Price
$39.76
Return
+75.2%
Tectonic Therapeutic Inc.
TECX
Jan 08, 2026
Signal & Target
BUY
$60.00
Start Price
$21.05
Best Price (1Y)
$36.02
Current Price
$30.28
Return
+43.8%
Insmed Inc
INSM
Dec 19, 2025
Signal & Target
BUY
$202.00
Start Price
$166.55
Best Price (1Y)
$186.19
Current Price
$97.46
Return
-41.5%
Centessa Pharmaceuticals plc - ADR
CNTA
Nov 05, 2025
Signal & Target
BUY
$30.00
Start Price
$19.15
Best Price (1Y)
$40.25
Current Price
$39.76
Return
+107.6%
Neurocrine Biosciences, Inc.
NBIX
Oct 29, 2025
Signal & Target
BUY
$172.00
Start Price
$139.90
Best Price (1Y)
$169.57
Current Price
$159.51
Return
+14.0%
Dianthus Therapeutics Inc
DNTH
Oct 14, 2025
Signal & Target
BUY
$56.00
Start Price
$34.42
Best Price (1Y)
$96.50
Current Price
$82.07
Return
+138.4%
Palvella Therapeutics, Inc.
PVLA
Oct 02, 2025
Signal & Target
BUY
$80.00
Start Price
$61.69
Best Price (1Y)
$151.18
Current Price
$108.81
Return
+76.4%
Alnylam Pharmaceuticals Inc
ALNY
Jul 21, 2025
Signal & Target
BUY
$385.00
Start Price
$324.49
Best Price (1Y)
$495.55
Current Price
$287.80
Return
-11.3%
Agios Pharmaceuticals Inc
AGIO
Oct 31, 2024
Signal & Target
BUY
$51.00
Start Price
$44.43
Best Price (1Y)
$62.58
Current Price
$31.82
Return
-28.4%
Regenxbio Inc
RGNX
Oct 10, 2024
Signal & Target
BUY
$18.00
Start Price
$9.19
Best Price (1Y)
$12.84
Current Price
$7.07
Return
-23.1%
Signal & Target
BUY
$79.00
Start Price
$69.60
Best Price (1Y)
$73.51
Current Price
$55.65
Return
-20.0%
Neurocrine Biosciences, Inc.
NBIX
Oct 10, 2024
Signal & Target
BUY
$155.00
Start Price
$111.62
Best Price (1Y)
$154.61
Current Price
$159.51
Return
+42.9%
Argen X SE - ADR
ARGX
Oct 10, 2024
Signal & Target
BUY
$605.00
Start Price
$520.52
Best Price (1Y)
$808.43
Current Price
$884.20
Return
+69.9%
Xenon Pharmaceuticals Inc
XENE
Oct 10, 2024
Signal & Target
BUY
$50.00
Start Price
$39.42
Best Price (1Y)
$46.00
Current Price
$52.40
Return
+32.9%
Disc Medicine Inc
IRON
Aug 08, 2024
Signal & Target
BUY
$50.00
Start Price
$42.85
Best Price (1Y)
$68.73
Current Price
$67.99
Return
+58.7%
BridgeBio Pharma Inc
BBIO
Jun 24, 2024
Signal & Target
BUY
$46.00
Start Price
$22.65
Best Price (1Y)
$44.75
Current Price
$68.00
Return
+200.2%
Disc Medicine Inc
IRON
May 10, 2024
Signal & Target
BUY
$43.00
Start Price
$29.95
Best Price (1Y)
$68.73
Current Price
$67.99
Return
+127.0%
Harmony Biosciences Holdings Inc
HRMY
Apr 30, 2024
Signal & Target
BUY
$37.00
Start Price
$30.91
Best Price (1Y)
$41.61
Current Price
$34.18
Return
+10.6%
Disc Medicine Inc
IRON
Apr 01, 2024
Signal & Target
BUY
$40.00
Start Price
$29.40
Best Price (1Y)
$68.73
Current Price
$67.99
Return
+131.3%
Xenon Pharmaceuticals Inc
XENE
Oct 18, 2022
Signal & Target
BUY
$52.00
Start Price
$35.52
Best Price (1Y)
-
Current Price
$52.40
Return
+47.5%
Neurocrine Biosciences, Inc.
NBIX
Feb 11, 2022
Signal & Target
BUY
$125.00
Start Price
$85.53
Best Price (1Y)
-
Current Price
$159.51
Return
+86.5%
uniQure N.V.
QURE
Dec 16, 2021
Signal & Target
BUY
$58.00
Start Price
$20.24
Best Price (1Y)
-
Current Price
$27.87
Return
+37.7%